IntroductionCervical cancer is staged preoperatively and the postoperative treatment depends on the combination of staging with histopathological finding. Survival is related to certain histopathological factors, most importantly lymph node status and other findings indicating that tumor may have spread i.e. parametrium and the lymph-vascular space. Other factors like tumor size and depth of stromal invasion indicate aggressive biological behavior. Poorer survival depending on histological type of tumor is reported in adenocarcinoma compared to squamous carcinoma [1][2][3][4][5][6][7]. The concurrent increasing incidence of adenocarcinoma associated with use of oral contraceptives in the Western World is a concern to that it may reverse the positive effect of screening [6,7]. However, the survival relates heavily on different pre-and postoperative treatment regimens and stage of disease [1,3,4]. Adverse histopathological factors are often present simultaneously and reviewed heterogeneously.The aim of our study was to evaluate independent histopathological factors for women with radical hysterectomy with focus on standardized histopathological diagnosis combined with similar pre-and postoperative treatment.
Material and Methods141 women were diagnosed with cervical cancer stage 1b and operated with radical hysterectomy during 24 years at Holstebro Hospital. The hospital served as centre for the county with a population of approximately 275.000. The stage, pre-and postoperative treatment was registered as the data charts were reviewed. The local patient registry provided information of survival, relapse, and re-admittance. None of the women was lost to follow-up. Data charts or post mortem sections confirmed the cause of death.
AbstractBackground: Evaluation of histopathological factors for women with radical hysterectomy a.m. Okabayashi for cervical cancer in stage 1bwith similar pre-and postoperative treatment Methods: Data on 141 women with cervical cancer stage 1b were revised. The local patient registry, data charts, and post mortem sections provided follow-up on survival, relapse, and re-admittance. Histopathological evaluation was performed by the same pathologist. Results: Histological evaluation showed that adenosquamous cervical cancer in stage 1b was associated with poorer survival than the pure squamous and adenomatous type (p<0.001, mixed versus pure type). Five year's survival rate was 40 % (2-78 %) for mixed type and 92 % (87-97 %) for pure type. The mixed type was associated with glandular metastasis (p<0.02). The relapse free survival after 5 and 10 years was 88 % (82-94 %) and 83 % (75-91 %), respectively, while survival was found to be 89 % (83-95 %) and 86 % (79-93 %), respectively. The women's age at diagnosis showed no association with histology type or survival.